Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Around 160 children visited the Department of Pharmacology stall at the ATOM festival in Abingdon at the weekend. Children engaged in activities to explain ‘How Medicines Work’ and the stall also attracted adults interested in discussing medicines. The Pharmacology stall was run by several of our MSc students (below from left: William Shieu, Laura Mereweather, Eesha Dinkar, left: Michelle Meng). In addition, Dr Barbara Zonta, MSc Course Director, and Dr Laurence Silpa, a postdoc in the Russell lab, were on hand to help out

Similar stories

EMA approval of IntraBio’s Aqneursa marks a major milestone for the Department of Pharmacology, with further Phase 3 success in Ataxia Telangiectasia

On 21 January, the European Medicines Agency (EMA) approved Aqneursa, a new treatment for Niemann-Pick Disease Type C (NPC) in adults and children, marking a major milestone for research originating in the Department of Pharmacology. Aqneursa already received US FDA approval (September 2024), enabling patient access on both sides of the Atlantic.